Paid Clinical Trials South Bend

Discover 156 paid clinical trials in South Bend, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 156

Thoracotomy vs. ThoracoscopicThoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

Recruiting

PHASE3

Sponsor:

Children's Oncology Group

Location:

Niles MI, Saint Joseph MI, Kalamazoo MI, Battle Creek MIshow 144 more

Code:

NCT05235165

Conditions

Metastatic Malignant Neoplasm in the Lung

Metastatic Osteosarcoma

Osteosarcoma

Eligibility Criteria

Sex: All

Age: 0 - 50

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Computed Tomography

Questionnaire Administration

Thoracoscopy

Thoracotomy

MilvexianA Study of Milvexian in Participants After a Recent Acute Coronary Syndrome

Recruiting

PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Elkhart IN, Fort Wayne IN, Chicago IL, Palos Hills ILshow 163 more

Code:

NCT05754957

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Milvexian

Placebo

Budesonide, Glycopyrronium, FormoterolA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Valparaiso IN, Chicago IL, Winfield IL, Cudahy WIshow 196 more

Code:

NCT06283966

Conditions

COPD (Chronic Obstructive Pulmonary Disease)

Eligibility Criteria

Sex: All

Age: 40 - 70+

Healthy Volunteers: Not accepted

Interventions

BGF MDI 320/14.4/9.6 μg

GFF MDI 14.4/9.6 μg

BDA with HFOA Study to Investigate the Effect on Lung Function of BDA Formulated With a New Propellant (HFO) Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

Recruiting

PHASE3

Sponsor:

AstraZeneca

Location:

Valparaiso IN, River Forest IL, Milwaukee WI, Flint MIshow 62 more

Code:

NCT06502366

Conditions

Asthma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BDA MDI HFO 160/180 μg

BDA MDI HFA 160/180 μg

Placebo MDI HFA

BupropionBupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Recruiting

PHASE3

Sponsor:

University of Rochester NCORP Research Base

Location:

Niles MI, Saint Joseph MI, Valparaiso IN, Hobart INshow 290 more

Code:

NCT03996265

Conditions

Be Diagnosed With Cancer and Have Completed Systemic Therapy

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bupropion Hydrochloride Controlled-release

Placebo Administration

Quality-of-Life Assessment

Questionnaire Administration

SurvodutideLIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Recruiting

PHASE3

Sponsor:

Boehringer Ingelheim

Location:

South Bend IN, Hammond IN, Wyoming MI, Springboro OHshow 69 more

Code:

NCT06632457

Conditions

Metabolic Dysfunction Associated Steatohepatitis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Survodutide

Placebo matching survodutide

LevocarnitineStudying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma

Recruiting

PHASE3

Sponsor:

Children's Oncology Group

Location:

Niles MI, Saint Joseph MI, Kalamazoo MI, Battle Creek MIshow 138 more

Code:

NCT05602194

Conditions

B Acute Lymphoblastic Leukemia

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1

B Acute Lymphoblastic Leukemia, BCR-ABL1-Like

Lymphoblastic Lymphoma

Mixed Phenotype Acute Leukemia

Eligibility Criteria

Sex: All

Age: 15 - 40

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Calaspargase Pegol

Levocarnitine

Pegaspargase

Quality-of-Life Assessment

AZD9550 & AZD6234A Weight Loss Study Evaluating Subcutaneous Treatment With AZD9550 and AZD6234 in Combination Against Placebo or Each of the Drugs Alone

Recruiting

PHASE2

Sponsor:

AstraZeneca

Location:

South Bend IN, Valparaiso IN, Champaign IL, Southfield MIshow 39 more

Code:

NCT06862791

Conditions

Obesity or Overweight

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

AZD9550

AZD6234

Placebo comparator

CrizotinibCrizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

Recruiting

PHASE3

Sponsor:

ECOG-ACRIN Cancer Research Group

Location:

South Bend IN, Mishawaka IN, Niles MI, Elkhart INshow 977 more

Code:

NCT02201992

Conditions

ALK Gene Rearrangement

ALK Gene Translocation

ALK Positive

Stage IB Non-Small Cell Lung Carcinoma AJCC v7

Stage II Non-Small Cell Lung Cancer AJCC v7

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Clinical Observation

Crizotinib

Laboratory Biomarker Analysis

Osimertinib & BevacizumabOsimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Valparaiso IN, Hobart IN, Crown Point IN, Munster INshow 422 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography Test

Magnetic Resonance Imaging